Why do we need a trial on the effects of testosterone therapy in older men?

N L Cook1, S Romashkan

  • 1Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.

Insights

Low testosterone in older men may cause adverse symptoms, but causality remains unclear. The Testosterone Trial investigated whether testosterone therapy improves physical, sexual, and cognitive function in elderly men with low levels.

Area of Science:

  • Endocrinology
  • Geriatrics
  • Men's Health

Background:

  • Sex hormone levels, particularly testosterone, decline with aging in men.
  • Observational studies suggest links between low testosterone and adverse symptoms in older men, but causality is not established.
  • Clinical decisions regarding testosterone replacement therapy in aging men with low levels require evidence of efficacy.

Purpose of the Study:

  • To investigate the efficacy of testosterone therapy in elderly men with documented low testosterone levels.
  • To assess the impact of testosterone therapy on physical function, sexual function, cognitive function, and vitality.
  • To address the clinical question of whether to treat older men with low serum testosterone.

Main Methods:

  • The Testosterone Trial (T Trial) was initiated in 2009.
  • The study enrolled 800 elderly men with low testosterone levels.
  • Participants were assessed for potential benefits of testosterone therapy on various health parameters.

Main Results:

  • The study aimed to determine if testosterone therapy offers significant benefits.
  • Results were intended to clarify the causal relationship between testosterone levels and age-related symptoms.
  • The trial focused on objective measures of physical, sexual, cognitive, and vitality outcomes.

Conclusions:

  • The Testosterone Trial provides crucial data on the efficacy of testosterone therapy in older men.
  • Findings will inform clinical practice regarding testosterone supplementation for age-related hypogonadism.
  • Evidence from the T Trial is essential for guiding treatment decisions in this demographic.

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...